Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05241873
Title Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Blueprint Medicines Corporation
Indications

lung non-small cell carcinoma

Therapies

BLU-451

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST